ESTAESTABLISHMENT LABS HOLDINGS INC.(ESTA)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNasdaqmid
Institutional-grade research for retail investors
SEC EDGAR: CIK 1688757ESTA stock profile & AI dashboard →

13F Pro Quality Score

33.9/100

Rank #2,368 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

80.7/100

Profitability

20.9/100

Balance Sheet

15.9/100

Earnings Quality

18.4/100

Free Cash Flow

13.8/100

Institutional Flow

6.9/100

Revenue Scale

26.4/100

Dilution Risk

23.8/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

ESTA Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ESTABLISHMENT LABS HOLDINGS INC. (ESTA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ESTA at 33.9/100 on a 32-signal composite quality model, placing it at rank #2,368 of 2,961 stocks — the bottom half of the AI-ranked universe. ESTA scores in the top quartile across revenue growth (80.7). Areas of concern include institutional flow (6.9) and free cash flow (13.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ESTABLISHMENT LABS HOLDINGS INC. reports quarterly revenue of $67.5M, net income of $-11.7M, free cash flow of $-20.3M. Top institutional holders of ESTA by reported 13-F value include JW Asset Management, RTW INVESTMENTS, BlackRock, based on the most recent SEC filings. ESTA trades on the Nasdaq exchange and files with the SEC under CIK 1688757. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ESTA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ESTABLISHMENT LABS HOLDINGS INC. directly from SEC EDGAR. ESTABLISHMENT LABS HOLDINGS INC.'s 13F Pro composite quality score has ranged between 21 and 34 since 2021, currently 33.9 — a stable long-term trajectory across 65 quarterly and live scoring snapshots.

Fun facts about ESTABLISHMENT LABS HOLDINGS INC.

Quirks, history, and lore behind ESTA — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    A medical device company · small-cap · listed on Nasdaq · headquartered in Costa Rica with U.S. offices in California.
  • 2
    The Numbers
    Annual revenue in the range of $200–300 million — modest by med-device standards — but growing fast in a market that's billions of dollars and largely recession-proof.
  • 3
    The History
    Founded in the 2010s, it set out to challenge the two giants that had long dominated breast implant surgery with a next-generation device and a data-driven approach.
  • 4
    The Secret
    Its flagship implant is built around a proprietary gel matrix technology designed to feel more natural and reduce the rupture and rippling complaints that haunted older products.
  • 5
    The Lore
    The company bets heavily on surgeon education and outcomes tracking, running a global registry so it can actually prove — with real-world data — that its implants perform better.
  • 6
    The Giveaway
    Its Motiva breast implant line is sold in over 80 countries, and the whole company exists to convince plastic surgeons that the incumbents' decades-old designs deserve to be disrupted.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$67.5M

Net Income

Q2 2026

$-11.7M

Free Cash Flow

Q2 2026

$-20.3M

ROIC

Q2 2026

-6.1%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+27.1% YoY
$211.1MFY 2025
FY22 $161.7MFY23 $165.2MFY24 $166.0MFY25 $211.1M

Net Income

+39.6% YoY
$-51.1MFY 2025
FY22 $-75.2MFY23 $-78.5MFY24 $-84.6MFY25 $-51.1M

Operating Income

+22.0% YoY
$-39.0MFY 2025
FY22 $-39.7MFY23 $-65.0MFY24 $-50.0MFY25 $-39.0M

EPS (Diluted)

+42.7% YoY
$-1.72FY 2025
FY22 $-3.08FY23 $-3.07FY24 $-3.00FY25 $-1.72

Total Assets

+3.0% YoY
$357.2MFY 2025
FY22 $211.1MFY23 $268.6MFY24 $346.8MFY25 $357.2M

Total Debt

+12.7% YoY
$247.5MFY 2025
FY22 $175.5MFY23 $188.7MFY24 $219.6MFY25 $247.5M

Op. Cash Flow

+13.0% YoY
$-50.9MFY 2025
FY22 $-52.2MFY23 $-88.5MFY24 $-58.5MFY25 $-50.9M

Free Cash Flow

+11.9% YoY
$-56.9MFY 2025
FY22 $-55.0MFY23 $-96.4MFY24 $-64.6MFY25 $-56.9M

Get alerted when ESTA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ESTABLISHMENT LABS HOLDINGS INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of ESTA

Companies Similar to ESTA

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ARDX

ARDELYX, INC.

38
AI score
Similar quality profile · 7 shared holders
SPRY

ARS Pharmaceuticals, Inc.

24
AI score
Similar quality profile · 9 shared holders
ATEC

Alphatec Holdings, Inc.

41
AI score
Similar quality profile · 8 shared holders
GH

Guardant Health, Inc.

39
AI score
Similar quality profile · 13 shared holders
SDGR

Schrodinger, Inc.

28
AI score
Similar quality profile · 5 shared holders
APYX

Apyx Medical Corp

27
AI score
Similar quality profile · 4 shared holders
WGS

GeneDx Holdings Corp.

35
AI score
Similar quality profile · 4 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put ESTA on your watchlist

Track score changes the day ESTABLISHMENT LABS HOLDINGS INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ESTA a good stock to buy?

13F Pro's AI-powered analysis of ESTABLISHMENT LABS HOLDINGS INC. (ESTA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ESTA are available on the ESTA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ESTA is classified as a mid company.

Which hedge funds own ESTA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ESTA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ESTABLISHMENT LABS HOLDINGS INC.'s investment landscape.